Video blog: HER2-targeted agents
PUBLISHED: 8:38 AM, SAT DECEMBER 10, 2011
Dr. Debu Tripathy explains the HER2 pathway's involvement in breast cancer and how new investigational drugs, including pertuzumab and TDM1, as well as combinations of new and approved drugs are targeting this pathway.
Hear financial expert and registered nurse Mary Ann Cagle discuss the financial burden of cancer, often a result of expensive treatments, appointments, and diagnostic tests. Learn where to look for possible financial support.